Does Atenolol Work for Migraines?
Atenolol is NOT FDA-approved for migraine prevention and should NOT be your first-line choice, despite having some evidence of efficacy. The 2025 American College of Physicians guideline does not include atenolol among its recommended first-line agents for episodic migraine prevention 1. The FDA label for atenolol lists only hypertension, angina pectoris, and acute myocardial infarction as approved indications—migraine is notably absent 2.
What the Evidence Actually Shows
While atenolol has demonstrated some effectiveness in older research studies, the evidence is limited:
- A 1980 comparative trial showed atenolol 50 mg twice daily was significantly better than placebo in reducing migraine attacks, though the study was small (28 patients) 3
- A 2013 open-label study (19 patients) showed atenolol 50 mg daily reduced headache days from 20.1 to 7.1 per month over 3 months in chronic migraine 4
- A 2006 review classified atenolol as having only "limited evidence" to support its use in migraine prevention 5
The critical problem: These are small, older studies. No large, high-quality randomized controlled trials have established atenolol's efficacy for migraine prevention by modern standards.
What You Should Use Instead
The 2025 ACP guideline recommends as first-line agents 1:
- Propranolol (not atenolol—this is the beta-blocker with the strongest evidence, proven effective in 19 of 21 controlled trials) 6
- Topiramate
- Divalproex/sodium valproate
- Amitriptyline
For chronic migraine specifically, the most recent high-quality evidence supports:
- CGRP antagonists (atogepant, fremanezumab, eptinezumab) with mean reductions of 2.5-2.8 migraine days per month 7, 8, 9
- Onabotulinumtoxin A 8
Why Atenolol Falls Short
Among beta-blockers, only those WITHOUT intrinsic sympathomimetic activity (ISA) are effective for migraine 6. While atenolol lacks ISA, it is cardioselective (β1-selective), which may make it less effective than non-selective beta-blockers like propranolol for migraine prevention. The mechanism of action in migraine likely involves reduction of brain catecholaminergic hyperactivity, which may require broader beta-receptor blockade 6.
Clinical Bottom Line
If you're considering a beta-blocker for migraine prevention, use propranolol (the evidence-based choice) rather than atenolol. Start propranolol at 40 mg twice daily and titrate up to 80-240 mg daily as tolerated. If propranolol is contraindicated (asthma, severe bradycardia, heart block), consider metoprolol, timolol, or nadolol—all have better evidence than atenolol 6, 5.
Atenolol might work based on limited data, but you're using an off-label medication with weak evidence when superior alternatives exist. This is particularly important given that migraine ranks as the second leading cause of global disability 1.
Key Caveat
One case report warns against using atenolol for migraine prophylaxis when arteriovenous malformation is suspected, as symptom control may delay diagnosis and expose patients to hemorrhage risk 10. Always ensure proper diagnostic workup before initiating preventive therapy.